ESMO-GI 2025, abstract

Oncosyne AS and Akershus University Hospital in Oslo had an abstract approved to present at ESMO-GI 2025 in Barcelona, ​​Spain between July 2-5, 2025.

Information about the abstract

Title: ”Cytotoxicity of arfolitixorin versus leucovorin (LEU) with 5-fluorouracil (5FU) and oxaliplatin in colorectal cancer (CRC) patient-derived tumoroids (PDTs)”

Authors: Peter Eide, Jarle Bruun, Sebastian Meltzer, Christer Andreassen, Teijo Pellinen, Godefridus J Peters, Marianne Svärd, Knut Augestad, Anne H. Ree, Roger Tell

Presentation Number: #128P

The abstract was published online on ESMO’s website and is also be available below:

Listen to Jarle Bruun, CEO Oncosyne